Latest

antidepressants

Brain Cancer Featured Neurology Neuroscience

·September 22, 2024·5 min read

Antidepressant May Help Fight Glioblastoma Brain Tumors

Researchers have discovered that the antidepressant vortioxetine effectively combats glioblastoma, a deadly brain tumor, in lab tests and in mice. This drug, already FDA-approved, crosses the blood-brain barrier and could potentially improve treatment for glioblastoma patients when combined with standard therapy.

This shows a head and psychedelic swirls.

Featured Neuroscience Psychology

·September 22, 2024·7 min read

Psilocybin Shows Greater Long-Term Benefits Over SSRI for Depression

A study comparing psilocybin to the SSRI escitalopram found both drugs improved depressive symptoms similarly over six months, but psilocybin offered additional psychosocial benefits. Patients taking psilocybin reported a greater sense of meaning, psychological connectedness, and improved social functioning. These results suggest psilocybin could provide a more holistic treatment option for depression, addressing both symptoms and overall well-being. While promising, psilocybin remains experimental and is only administered in controlled environments.

Featured Neuroscience Psychology

·June 6, 2024·8 min read

1 in 6 Antidepressant Users Face Withdrawal Symptoms

15% of people stopping antidepressants experience withdrawal symptoms like dizziness and nausea, while 3% face severe symptoms. The research highlights the need for careful management and counseling by healthcare professionals when discontinuing antidepressants. This study aims to provide a balanced view on the real prevalence of withdrawal symptoms and their impact.

Featured Neuroscience Psychology

·June 6, 2024·4 min read

How Antidepressants Treat Major Depression

Researchers have developed a new framework explaining how antidepressants, like SSRIs, treat major depressive disorder (MDD) by restoring brain connectivity rather than correcting a serotonin imbalance. Their findings emphasize the continued importance of these medications despite shifting public opinion. This new understanding could improve patient-clinician conversations about depression treatment.

Featured Neuroscience Psychology

·May 30, 2024·6 min read

AI Tool Matches Patients to Effective Antidepressants Faster

Researchers developed an AI-based tool, MeAgainMeds.com, to help match patients with the most effective antidepressants based on their medical history. This free website aims to reduce the trial-and-error process in finding the right medication, improving patient outcomes.

Featured Neuroscience Psychology

·May 8, 2024·5 min read

Psychedelics Activate Serotonin to Produce Antidepressant Effect

A new study advanced our understanding of how psychedelic drugs activate serotonin receptors to offer potential treatments for neuropsychiatric disorders. The identifies the interaction of psychedelics like LSD and psilocybin with the serotonin receptor 5-HT1A, which is pivotal in their therapeutic effects.

Featured Neuroscience Psychology

·May 2, 2024·7 min read

Psilocybin Effective as Antidepressant

Psilocybin, the psychoactive compound in magic mushrooms, is notably more effective at alleviating depression symptoms than conventional controls. Analyzing seven trials with 436 participants, researchers found a substantial improvement in depression scores following psilocybin treatment compared to placebos or other minor psychedelic doses, showcasing a large effect size.

Featured Neuroscience Psychology

·February 16, 2024·3 min read

Antidepressants Impact Brain Development

Using antidepressants during pregnancy, specifically fluoxetine (found in Prozac and Sarafem), can significantly affect a child's brain development, particularly in the prefrontal cortex, potentially increasing the risk of mental health disorders later in life. The research highlights how serotonin, boosted by fluoxetine, directly impacts the development of synaptic connections in the prefrontal cortex, a critical area for high-order cognitive functions.

Featured Neuroscience Psychology

·February 7, 2024·3 min read

AI Predicts Antidepressant Success in a Week

Researchers developed an AI algorithm that, by analyzing brain scans and clinical information, can predict within a week whether an antidepressant will work for patients with major depression disorder. This method could potentially avoid unnecessary prescriptions of sertraline, a commonly used antidepressant, by identifying non-responders early, thus offering better patient care and reducing side effects.

Featured Neuroscience Psychology

·January 16, 2024·6 min read

Emotional and Social Toll of Antidepressant Withdrawal

New research reveals that coming off antidepressants like Prozac can cause not only physical symptoms but also emotional, cognitive, and social difficulties. The study involved in-depth interviews with 20 individuals who attempted to withdraw from SSRIs in the past year, highlighting the complex challenges they faced, including emotional overwhelm, reduced enjoyment in social situations, and a feeling of detachment.

Featured Neuroscience Psychology

·October 19, 2023·6 min read

Does Drug Effect or Power of Belief Explain Ketamine’s Antidepressant Effect?

Researchers conducted a unique study to uncover the efficacy of ketamine in treating depression, bypassing its unmistakable psychedelic effects by administering it during surgery. Surprisingly, both the ketamine and placebo groups showed substantial improvement in depression symptoms.

Featured Neuroscience Psychology

·October 7, 2023·6 min read

Running Parallels Antidepressants in Reducing Depression

Researchers offered 141 patients with anxiety and/or depression a choice between 16 weeks of SSRIs (antidepressants) or group running therapy, revealing both options approximately equally benefited mental health. However, physical health improvements—including weight, waist circumference, and cardiovascular function—were notably observed in the running group, despite a higher dropout rate.